Ang Lifesciences India share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹29.80(2.87%)March 18, 2025 15:23:17 PM IST
- NSE
- BSE
- Vol : 37.42K (NSE + BSE)Last 20 day avg : 11.84 K
Ang Lifesciences India is trading 2.87% upper at Rs 29.80 as compared to its last closing price. Ang Lifesciences India has been trading in the price range of 31.70 & 28.21. Ang Lifesciences India has given -35.07% in this year & -14.94% in the last 5 days. The company posted a net profit of -5.19 Crores in its last quarter.Listed peers of Ang Lifesciences India include Gujarat Inject Kerala (1.78%), Medico Intercontinental (-0.94%), Ang Lifesciences India (2.87%).The Mutual Fund holding in Ang Lifesciences India was at -% in . The MF holding has - from the last quarter. The FII holding in Ang Lifesciences India was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Mar 18, 2025, 10:27 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.50The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.53Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.95The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Ang Lifesciences India News
Ang Lifesciences India Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is not profitable
The company's revenue grew in December quarter by 33.34% from Rs 24.73 crore to Rs 18.55 crore, year-on-year- The company has reduced its December quarter loss by 12.48% from Rs 5.93 crore to Rs 5.19 crore, year-on-year
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
Ang Lifesciences India Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 37.30
- R2
- 40.65
- R3
- 45.30
Pivot32.65
- S1
- 29.30
- S2
- 24.65
- S3
- 21.30
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Ang Lifesciences India Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Gujarat Inject Kerala | Bullish | 27.48 | 1.78 | 40.25 | 309.67 | 3.69 | - | - |
| Medico Intercontinental | Bearish | 39.16 | -0.94 | 39.28 | 10.22 | 0.9 | - | 4.15 |
| Ang Lifesciences India | Bearish | 29.80 | 2.87 | 39.10 | - | 0.52 | - | 21.92 |
| Aa Plus Tradelink | Neutral | 1.59 | - | 38.68 | 24.12 | 0.97 | - | - |
| Concord Drugs | Neutral | 33.79 | -0.73 | 34.83 | 75.13 | 1.05 | - | 1.91 |
Ang Lifesciences India Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Ang Lifesciences India is currently unavailable
Please check back later.
Shareholding Insights
- Pledged found - Promoter(s) have pledged 44.88% of shares.
- Pledging Flat - Promoter(s) pledging has not increased in last quarter.
- Promoter(s) holds a high stake in the company at 70.60%
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Ang Lifesciences India Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| 2024-05-30 | Audited Results |
| 2024-02-14 | Quarterly Results |
About the company Ang Lifesciences India
- IndustryBiotechnology & Drugs
- ISININE236W01016
- BSE Code540694
- NSE Code
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.
Ang Lifesciences India Share Price FAQs
Ang Lifesciences India is trading at 29.80 as on Tue Mar 18 2025 09:53:17. This is 2.87% upper as compared to its previous closing price of 28.97.
The market capitalization of Ang Lifesciences India is 39.10 Cr as on Tue Mar 18 2025 09:53:17.
The 52 wk high for Ang Lifesciences India is 63.17 whereas the 52 wk low is 28.00
Ang Lifesciences India can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 28.62
- Dividend Yield: 0.00%
- D/E ratio: -
Ang Lifesciences India reported a net profit of -10.14 Cr in 2024.
Quick Links